CLINICAL TRIALS PROFILE FOR SEPTRA GRAPE

All Clinical Trials for SEPTRA GRAPE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000655 ↗	A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients	Completed	Glaxo Wellcome	Phase 2	1969-12-31	To evaluate the effectiveness of atovaquone (566C80) compared to a standard antipneumocystis agent, (SMX/TMP), for the treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in AIDS patients. To compare the safety of short-term (21 days) treatment with 566C80 and SMX/TMP in AIDS patients with an acute episode of PCP. Standard therapies for acute treatment of PCP involve either SMX/TMP or pentamidine isetionate. Although both treatments are equally effective, side effects prevent completion of therapy in 11-55 percent of patients.
NCT00000655 ↗	A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	1969-12-31	To evaluate the effectiveness of atovaquone (566C80) compared to a standard antipneumocystis agent, (SMX/TMP), for the treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) in AIDS patients. To compare the safety of short-term (21 days) treatment with 566C80 and SMX/TMP in AIDS patients with an acute episode of PCP. Standard therapies for acute treatment of PCP involve either SMX/TMP or pentamidine isetionate. Although both treatments are equally effective, side effects prevent completion of therapy in 11-55 percent of patients.
NCT00002524 ↗	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma	Completed	National Cancer Institute (NCI)	Phase 2	1993-06-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
NCT00002524 ↗	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma	Completed	M.D. Anderson Cancer Center	Phase 2	1993-06-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
NCT00002850 ↗	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	Eastern Cooperative Oncology Group	Phase 3	1997-03-01	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.
NCT00002850 ↗	Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy	Completed	National Cancer Institute (NCI)	Phase 3	1997-03-01	RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma.

Clinical Trial Conditions for SEPTRA GRAPE

Condition Name

Condition Name for SEPTRA GRAPE
Intervention	Trials
Urinary Tract Infection	5
Abscess	3
HIV Infections	2
Infection	2

Condition MeSH

Condition MeSH for SEPTRA GRAPE
Intervention	Trials
Infections	8
Infection	8
Communicable Diseases	7
Urinary Tract Infections	5

Clinical Trial Locations for SEPTRA GRAPE

Trials by Country

Trials by Country for SEPTRA GRAPE
Location	Trials
United States	53
Canada	7
Belgium	3
France	2
Botswana	2

Trials by US State

Trials by US State for SEPTRA GRAPE
Location	Trials
Texas	6
Washington	4
Ohio	4
New York	4
Missouri	4

Clinical Trial Progress for SEPTRA GRAPE

Clinical Trial Phase

Clinical Trial Phase for SEPTRA GRAPE
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	2
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for SEPTRA GRAPE
Clinical Trial Phase	Trials
Completed	14
Recruiting	5
Unknown status	3

Clinical Trial Sponsors for SEPTRA GRAPE

Sponsor Name

Sponsor Name for SEPTRA GRAPE
Sponsor	Trials
National Cancer Institute (NCI)	4
University of Washington	3
National Institute of Allergy and Infectious Diseases (NIAID)	2

Sponsor Type

Sponsor Type for SEPTRA GRAPE
Sponsor	Trials
Other	41
NIH	9
U.S. Fed	5